Abstract
Background
Poor adherence habits are key contributors to nonadherence but there are few clinically feasible methods for evaluating adherence habits, particularly for youths with chronic kidney disease (CKD). This study investigated how participants’ qualitative responses to three interview questions about adherence habits mapped to primary principles of habit formation and objectively measured medication adherence in youths with CKD.
Methods
Participants (ages 11–21 years) were recruited from a pediatric nephrology clinic as part of a larger study. Participants’ daily objective antihypertensive medication adherence was measured with an electronic pill bottle over a 4-week baseline period. Qualitative interviews about adherence habits and routines were conducted with a subset of participants (N = 18).
Results
Clear qualitative differences emerged in how participants with high-medium adherence (80–100%) discussed adherence habits compared to participants with low adherence (0–79%). Participants with high-medium adherence discussed situational cues for taking medicine, including locations that cue adherence, step-by-step events leading up to taking medicine, and people who cue adherence. Participants with high-medium adherence regularly described taking medicine as “automatic,” “second nature,” and a “habit.” Participants with low adherence rarely discussed these habit features nor did they explicitly acknowledge currently missing doses. Participants with low adherence tended to discuss challenges with organization and routines for taking medicine.
Conclusions
Evaluating patient responses to questions about adherence habits may uncover challenges with adherence habit formation, provide direction for habit-strengthening intervention focused on developing automatic cues for taking medication, and support adherence successes for youths with CKD.
Clinical trial registration number
NCT03651596.
Graphical abstract
Similar content being viewed by others
Abbreviations
- CKD:
-
Chronic kidney disease
References
Wühl E, Schaefer F (2008) Therapeutic strategies to slow chronic kidney disease progression. Pediatr Nephrol 23:705–716. https://doi.org/10.1007/s00467-008-0789-y
Wühl E, Mehls O, Schaefer F (2004) Antihypertensive and antiproteinuric efficacy of ramiprilin children with chronic renal failure. Kidney Int 66:768–776. https://doi.org/10.1111/j.1523-1755.2004.00802.x
Pruette CS, Coburn SS, Eaton CK, Brady TM et al (2019) Does a multimethod approach improve identification of medication nonadherence in adolescents with chronic kidney disease? Pediatr Nephrol 34:97–105. https://doi.org/10.1007/s00467-018-4044-x
Arden MA, Drabble S, O’Cathain A, Hutchings M, Wildman M (2019) Adherence to medication in adults with cystic fibrosis: an investigation using objective adherence data and the Theoretical Domains Framework. Br J Health Psychol 24:357–380. https://doi.org/10.1111/bjhp.12357
Hoo ZH, Gardner B, Arden MA, Waterhouse S et al (2019) Role of habit in treatment adherence among adults with cystic fibrosis. Thorax 74:197–199. https://doi.org/10.1136/thoraxjnl-2017-211453
Phillips LA, Cohen J, Burns E, Abrams J, Renninger S (2016) Self-management of chronic illness: the role of ‘habit’ versus reflective factors in exercise and medication adherence. J Behav Med 39:1076–1091. https://doi.org/10.1007/s10865-016-9732-z
Alison Phillips L, Leventhal H, Leventhal EA (2013) Assessing theoretical predictors of long-term medication adherence: patients’ treatment-related beliefs, experiential feedback and habit development. Psychol Health 28:1135–1151. https://doi.org/10.1080/08870446.2013.793798
Yeh EA, Chiang N, Darshan B, Nejati N et al (2019) Adherence in youth with multiple sclerosis: a qualitative assessment of habit formation, barriers, and facilitators. Qual Health Res 29:645–657. https://doi.org/10.1177/1049732318779039
Hoegy D, Bleyzac N, Rochet C, De Freminville H et al (2019) Medication adherence after pediatric allogeneic stem cell transplantation: barriers and facilitators. Eur J Oncol Nurs 38:1–7. https://doi.org/10.1016/j.ejon.2018.11.006
Claes A, Decorte A, Levtchenko E, Knops N, Dobbels F (2014) Facilitators and barriers of medication adherence in pediatric liver and kidney transplant recipients: a mixed-methods study. Prog Transplant 24:311–321. https://doi.org/10.7182/pit2014873
Gardner B (2015) A review and analysis of the use of ‘habit’ in understanding, predicting and influencing health-related behaviour. Health Psychol Rev 9:277–295. https://doi.org/10.1080/17437199.2013.876238
Wood W, Neal DT (2007) A new look at habits and the habit-goal interface. Psychol Rev 114:843–863. https://doi.org/10.1037/0033-295X.114.4.843
Gardner B, Abraham C, Lally P, de Bruijn GJ (2012) Towards parsimony in habit measurement: testing the convergent and predictive validity of an automaticity subscale of the Self-Report Habit Index. Int J Behav Nutr Phys Act 9:102. https://doi.org/10.1186/1479-5868-9-102
Verplanken B, Orbell S (2003) Reflections on past behavior: a self-report index of habit strength 1. J Appl Soc Psychol 33:1313–1330. https://doi.org/10.1111/j.1559-1816.2003.tb01951.x
Eaton CK, Eakin MN, Coburn S, Pruette CS et al (2019) Patient health beliefs and characteristics predict longitudinal antihypertensive medication adherence in adolescents with CKD. J Pediatr Psychol 44:40–51. https://doi.org/10.1093/jpepsy/jsy073
Eaton C, Comer M, Pruette C, Psoter K, Riekert K (2020) Text messaging adherence intervention for adolescents and young adults with chronic kidney disease: pilot randomized controlled trial and stakeholder interviews. J Med Internet Res 22:e19861. https://doi.org/10.2196/19861
Simons LE, McCormick ML, Devine K, Blount RL (2010) Medication barriers predict adolescent transplant recipients’ adherence and clinical outcomes at 18-month follow-up. J Pediatr Psychol 35:1038–1048. https://doi.org/10.1093/jpepsy/jsq025
Eaton CK, Lee JL, Simons LE, Devine KA, Mee LL, Blount RL (2015) Clinical cutoffs for adherence barriers in solid organ transplant recipients: how many is too many? J Pediatr Psychol 40:431–441. https://doi.org/10.1093/jpepsy/jsu102
Wu YP, Pai ALH, Gray WN, Denson LA, Hommel KA (2013) Development and reliability of a correction factor for family-reported medication adherence: pediatric inflammatory bowel disease as an exemplar. J Pediatr Psychol 38:893–901. https://doi.org/10.1093/jpepsy/jst043
Katz LL, Anderson BJ, McKay SV, Izquierdo R et al (2016) Correlates of medication adherence in the TODAY cohort of youth with type 2 diabetes. Diabetes Care 39:1956–1962. https://doi.org/10.2337/dc15-2296
LeLeiko NS, Lobato D, Hagin S, McQuaid E et al (2013) Rates and predictors of oral medication adherence in pediatric patients with IBD. Inflamm Bowel Dis 19:832–839. https://doi.org/10.1097/MIB.0b013e3182802b57
Hommel KA, Davis CM, Baldassano RN (2009) Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis 15:589–593. https://doi.org/10.1002/ibd.20798
Berg CJ, Rapoff MA, Snyder CR, Belmont JM (2007) The relationship of children’s hope to pediatric asthma treatment adherence. J Posit Psychol 2:176–184. https://doi.org/10.1080/17439760701409629
Marckmann M, Hermansen MN, Hansen KS, Chawes BL (2020) Assessment of adherence to asthma controllers in children and adolescents. Pediatr Allergy Immunol 31:930–937. https://doi.org/10.1111/pai.13312
Holbein CE, Smith AW, Peugh J, Modi AC (2019) Allocation of treatment responsibility in adolescents with epilepsy: associations with cognitive skills and medication adherence. J Pediatr Psychol 44:72–83. https://doi.org/10.1093/jpepsy/jsy006
Gutiérrez-Colina AM, Eaton CK, Lee JL, Reed-Knight B et al (2016) Executive functioning, barriers to adherence, and nonadherence in adolescent and young adult transplant recipients. J Pediatr Psychol 41:759–767. https://doi.org/10.1093/jpepsy/jsv107
Ding K, Reynolds CM, Driscoll KA, Janicke DM (2021) The relationship between executive functioning, type 1 diabetes self-management behaviors, and glycemic control in adolescents and young adults. Curr Diab Rep 21:10. https://doi.org/10.1007/s11892-021-01379-3
Johnson RJ, Harshman LA (2021) Neurocognition in pediatric chronic kidney disease: a review of data from the Chronic Kidney Disease in Children (CKiD) study. Semin Nephrol 41:446–454. https://doi.org/10.1016/j.semnephrol.2021.09.007
Gardner B, Phillips LA, Judah G (2016) Habitual instigation and habitual execution: Definition, measurement, and effects on behaviour frequency. Br J Health Psychol 21:613–630. https://doi.org/10.1111/bjhp.12189
Gardner B, Lally P, Wardle J (2012) Making health habitual: the psychology of ‘habit-formation’ and general practice. Br J Gen Pract 62:664–666. https://doi.org/10.3399/bjgp12X659466
Schaefer MR, Kavookjian J (2017) The impact of motivational interviewing on adherence and symptom severity in adolescents and young adults with chronic illness: a systematic review. Patient Educ Couns 100:2190–2199. https://doi.org/10.1016/j.pec.2017.05.037
Caccavale LJ, Corona R, LaRose JG, Mazzeo SE, Sova AR, Bean MK (2019) Exploring the role of motivational interviewing in adolescent patient-provider communication about type 1 diabetes. Pediatr Diabetes 20:217–225. https://doi.org/10.1111/pedi.12810
Glenn TW, Riekert KA, Roter D, Eakin MN et al (2021) Engagement and affective communication during pediatric nephrology clinic visits: associations with medication adherence. Patient Educ Couns 104:578–584. https://doi.org/10.1016/j.pec.2020.08.039
Ellingson LD, Lansing JE, DeShaw KJ, Peyer KL, Bai Y, Perez M, Phillips LA, Welk GJ (2019) Evaluating motivational interviewing and habit formation to enhance the effect of activity trackers on healthy adults’ activity levels: randomized intervention. JMIR MHealth UHealth 7:e10988. https://doi.org/10.2196/10988
Kaushal N, Rhodes RE, Spence JC, Meldrum JT (2017) Increasing physical activity through principles of habit formation in new gym members: a randomized controlled trial. Ann Behav Med 51:578–586. https://doi.org/10.1007/s12160-017-9881-5
Acknowledgements
The authors thank Tumasi Agyapong, Eric Fei, Merry Qian, You Wang, and Marin Langlieb for their contributions to the conduct of this investigation.
Funding
This study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Ruth L. Kirschstein Postdoctoral Individual National Research Service Award (F32DK118988), and the Society of Pediatric Psychology/American Psychological Association Division 54 Drotar-Crawford Postdoctoral Fellowship Research Grant (both awarded to C.K.E.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Eaton, C.K., Comer, M., Pruette, C.S. et al. Medication adherence in youths with CKD: habits for success. Pediatr Nephrol 38, 3791–3802 (2023). https://doi.org/10.1007/s00467-023-05976-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-023-05976-0